Gastrointestinal Cancer News

BARCELONA —  Nexavar plus a chemotherapy regimen was not superior to Nexavar alone in improving overall survival in a cohort of patients with hepatocellular carcinoma, according to findings presented at the International Liver Congress.

NEW ORLEANS — Lewis Cantley, PhD, director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, describes how KRAS-mutant colorectal cancers appear susceptible to vitamin C.

NEW ORLEANS — An analysis of five populations in a multiethnic cohort showed native Hawaiians demonstrated the greatest risk for pancreatic cancer, followed by black individuals, Japanese Americans, white individuals and Latinos.

NEW ORLEANS — The oral anticancer drug entrectinib appeared safe and effective for the treatment of patients with several types of cancer who harbored NTRK, ROS1 and ALK alterations and were not previously treated with targeted therapies, according to data presented at the American Association for Cancer Research Annual Meeting.

NEW ORLEANS — The investigational agent LOXO-101 demonstrated clinical activity in patients with solid tumors that had neurotrophic tyrosine receptor kinase gene fusions, according to study results presented at the American Association for Cancer Research Annual Meeting.

NEW ORLEANS — Filip Janku, MD, PhD, medical oncologist at The University of Texas MD Anderson Cancer Center, spoke to HemOnc Today about the clinical utility of liquid biopsies.

NEW ORLEANS — An immunotherapy that uses genetically engineered CD4 T cells to target the MAGE-A3 protein in cancer cells safely treated patients with metastatic cancers, according to data presented at the American Association for Cancer Research Annual Meeting.

NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting.

The U.S. Preventive Services Task Force has issued a final recommendation statement in support of the initiation of aspirin for the primary prevention of cardiovascular disease and colorectal cancer.

Three members of Fox Chase Cancer Center’s staff received special honors or awards this spring.